• Mon, January 3, 2022

by: WOPRAI

Joseph Spak Maintained (TSLA) at Hold with Increased Target to $335 on, Jan 3rd, 2022

by: WOPRAI

Ryan Brinkman Maintained (TSLA) at Sell with Increased Target to $98 on, Jan 3rd, 2022

by: WOPRAI

Emmanuel Rosner Maintained (TSLA) at Strong Buy with Increased Target to $400 on, Jan 3rd, 2022

by: WOPRAI

Adam Jonas Maintained (TSLA) at Buy on, Jan 3rd, 2022

by: WOPRAI

Garrett Nelson Upgraded (TSLA) to Strong Buy on, Jan 3rd, 2022

by: WOPRAI

Jason Goldberg Downgraded (USB) to Hold and Held Target at $68 on, Jan 3rd, 2022

by: WOPRAI

David George Maintained (USB) at Hold and Held Target at $55 on, Jan 3rd, 2022

by: WOPRAI

Ike Boruchow Maintained (VFC) at Buy and Held Target at $85 on, Jan 3rd, 2022

by: WOPRAI

Bernie McTernan Initiated (VCSA) at Strong Buy and Held Target at $260 on, Jan 3rd, 2022

by: WOPRAI

Derek Johnston Maintained (VTR) at Strong Buy with Decreased Target to $64 on, Jan 3rd, 2022

by: WOPRAI

Derek Johnston Maintained (WELL) at Strong Buy with Increased Target to $103 on, Jan 3rd, 2022

by: WOPRAI

Harsh Kumar Upgraded (WOLF) to Buy and Increased Target to $160 on, Jan 3rd, 2022

by: WOPRAI

Jason Goldberg Upgraded (WFC) to Buy and Increased Target to $62 on, Jan 3rd, 2022

by: WOPRAI

David George Maintained (WFC) at Buy and Held Target at $50 on, Jan 3rd, 2022

by: WOPRAI

Jeffrey Sprague Downgraded (TT) to Hold and Held Target at $214 on, Jan 3rd, 2022

by: WOPRAI

Tessa Romero Maintained (YMAB) at Hold with Decreased Target to $27 on, Jan 3rd, 2022

by: WOPRAI

Hamed Khorsand Upgraded (XPER) to Strong Buy on, Jan 3rd, 2022

by: WOPRAI

Bascome Majors Maintained (UNP) at Buy with Increased Target to $300 on, Jan 3rd, 2022

by: WOPRAI

Devin McDermott Maintained (APA) at Buy with Increased Target to $39 on, Jan 3rd, 2022

by: WOPRAI

Aaron Gal Maintained (ABBV) at Buy with Increased Target to $155 on, Jan 3rd, 2022

by: WOPRAI

Christopher Raymond Maintained (ABBV) at Buy with Increased Target to $160 on, Jan 3rd, 2022

by: WOPRAI

Derek Johnston Upgraded (BXP) to Strong Buy and Increased Target to $131 on, Jan 3rd, 2022

by: WOPRAI

Michael Schmitz Maintained (BPMC) at Strong Buy with Increased Target to $122 on, Jan 3rd, 2022

by: WOPRAI

Anupam Rama Maintained (ATRA) at Buy with Increased Target to $675 on, Jan 3rd, 2022

by: WOPRAI

Derek Johnston Upgraded (AVB) to Strong Buy and Increased Target to $285 on, Jan 3rd, 2022

by: WOPRAI

Jason Goldberg Maintained (BAC) at Buy with Increased Target to $58 on, Jan 3rd, 2022

by: WOPRAI

Edward Tenthoff Upgraded (ALNY) to Buy and Increased Target to $208 on, Jan 3rd, 2022

by: WOPRAI

Jeffrey Sprague Downgraded (CARR) to Hold and Held Target at $57 on, Jan 3rd, 2022

by: WOPRAI

Nicole Miller Regan Downgraded (CAKE) to Hold and Decreased Target to $44 on, Jan 3rd, 2022

by: WOPRAI

Jason Goldberg Maintained (C) at Hold with Decreased Target to $73 on, Jan 3rd, 2022

by: WOPRAI

David Barden Maintained (CCI) at Strong Buy with Increased Target to $224 on, Jan 3rd, 2022

by: WOPRAI

Vincent Caintic Downgraded (SYF) to Hold on, Jan 3rd, 2022

by: WOPRAI

Jason Goldberg Maintained (STT) at Buy with Increased Target to $130 on, Jan 3rd, 2022

by: WOPRAI

Dara Mohsenian Maintained (STZ) at Buy with Increased Target to $303 on, Jan 3rd, 2022

by: WOPRAI

Andrea Teixeira Maintained (STZ) at Buy with Increased Target to $283 on, Jan 3rd, 2022

by: WOPRAI

Steve Powers Maintained (STZ) at Hold with Increased Target to $240 on, Jan 3rd, 2022

  • Fri, December 31, 2021

by: WOPRAI

Lauren Lieberman Maintained (STZ) at Buy with Increased Target to $271 on, Dec 31st, 2021

by: WOPRAI

Kevin Cassidy Maintained (SYNA) at Strong Buy with Increased Target to $345 on, Dec 31st, 2021

by: WOPRAI

Jason Goldberg Maintained (TFC) at Hold and Held Target at $72 on, Dec 31st, 2021

by: WOPRAI

Emmanuel Rosner Maintained (TSLA) at Strong Buy with Increased Target to $400 on, Dec 31st, 2021

by: WOPRAI

Oren Livnat Maintained (XERS) at Strong Buy with Increased Target to $5.4 on, Dec 31st, 2021

by: WOPRAI

Roanna Ruiz Maintained (XERS) at Buy with Increased Target to $8 on, Dec 31st, 2021

  • Sun, January 2, 2022

by: WOPRAI

Mark Altschwager Maintained (ULTA) at Buy and Held Target at $480 on, Jan 2nd, 2022

by: WOPRAI

Mark Altschwager Maintained (TJX) at Buy and Held Target at $88 on, Jan 2nd, 2022

by: WOPRAI

Mark Delaney Maintained (TSLA) at Strong Buy on, Jan 2nd, 2022

by: WOPRAI

Philippe Houchois Maintained (TSLA) at Strong Buy on, Jan 2nd, 2022

  • Tue, January 4, 2022

by: WOPRAI

Matthew Boss Maintained (URBN) at Hold with Decreased Target to $34 on, Jan 4th, 2022

by: WOPRAI

Elemer Piros Upgraded (UBX) to Strong Buy and Held Target at $40 on, Jan 4th, 2022

Oren Livnat Maintained (XERS) at Strong Buy with Increased Target to $5.4 on, Dec 31st, 2021

Oren Livnat of HC Wainwright & Co., Maintained "Xeris Biopharma Holdings, Inc." (XERS) at Strong Buy with Increased Target from $4.25 to $5.4 on, Dec 31st, 2021.

Oren, nor any peers, have made any analyst calls on XERS in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30

Like: 👍